SEX DISPARITY OF THE ASSOCIATION BETWEEN PULSE PRESSURE AND CARDIOVASCULAR EVENTS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/8ed092850089398dc26008375dd29701.pdf
SEX DISPARITY OF THE ASSOCIATION BETWEEN PULSE PRESSURE AND CARDIOVASCULAR EVENTS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Natanon
Chamnarnphol
Natanon Chamnarnphol natanon.c@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States *
Panchanit Yongkiatkan panchanityk@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States -
Sorawis Ngaohirunpat sorawis.ngao@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States -
Issaree Boonyawannukul doctorpoundpoundz.fbi@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States - Faculty of Medicine Srinagarind Hospital Khon Kaen University Khon Kaen Thailand
Nongnapas Assawamasbunlue nongnapas.assawa@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States -
Napat Wongmat napat.6402@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States -
Thanin Asawaroekwisoot thaninasawaroekwisoot@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States -
Darinorn Pleanrungsi darinorn.ple@student.mahidol.edu American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States - Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
Katanyu Siwawut katanyu.siw@student.mahidol.edu American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States - Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
Thanasin Chalermchat thanasin.cha@student.mahidol.edu American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States - Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
Nopavit Mohpichai nopavit.moh@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States - Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok Thailand
Raynah Silprasert raynahroypim@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States -
Kyunghee Lee hicaru1004@hanmail.net American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States - Division of Nephrology, Department of Internal Medicine Daegu Veterans Health Service Medical Center Daegu Korea (Republic of)
Surasak Kantachuvesiri surasak.kan@mahidol.ac.th xcellent Center for Organ Transplantation Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok Thailand -
Ekamol Tantisattamo ekamoltan@gmail.com American Heart Association Comprehensive Hypertension Center at the University of California Irvine Medical Center, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine Orange, CA United States - xcellent Center for Organ Transplantation Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok Thailand Nephrology Section, Department of Medicine, Tibor Rubin Veterans Affairs Medical Center Veterans Affairs Long Beach Healthcare System Long Beach, CA United States

Pulse pressure (PP) has been linked to the risk of cardiovascular events (CVE). However, its relationship among different genders remains unclear. We aim to examine the association of PP with CVE in male and female participants.

A retrospective cross-sectional study was conducted using data from the 2017-2023 National Health and Nutrition Examination Survey (NHANES) database. PP was calculated as difference between mean systolic blood pressure (SBP) and mean diastolic blood pressure (DBP) and categorized into tertiles. CVE was defined by composite of acute myocardial infarction, coronary heart disease, stroke, and heart failure. Multi-variable logistic regression adjusted for age, demographic data and other comorbidities was used to examine the association between tertiles of PP and CVE, stratified by sex.

Among the 2,815 adults, mean age±SD was 53.2±16.8 years, 43.9% were white, 39.8% were male, and 43.1% were hypertensive. The mean SBP and DBP were 126±19.1 and 75.1±11.9 mmHg, respectively. The mean, P33.3, P50 and P67 of PP were 50.9±15.2, 43, 48 and 54 mmHg, respectively. In fully adjusted models, the participants in the 3rd tertiles (T3) had 41% higher odds of experiencing at least one CVE (aORT3 1.41(1.01-1.97) P 0.041, compared to the 1st tertiles (T1)). In subgroup analysis by gender, there was a higher PP-CVE association in female participants (aORT3 1.77(1.03-3.09) P 0.041), but the association was not observed in male participants (aORT3 1.34(0.87-2.07) P 0.186)This study demonstrates a significant association between elevated PPandCVE, particularly among female participants. Further prospective studies are warranted to explore underlying mechanisms and to determine whether sex-specific strategies may enhance cardiovascular risk prediction and prevention.

This study demonstrates a significant association between elevated PP and CVE, particularly among female participants. Further prospective studies are warranted to explore underlying mechanisms and to determine whether sex-specific strategies may enhance cardiovascular risk prediction and prevention.


Kewords